{"url_path":"/sec/shph/8-k/2026-06-11/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-11","source_url":"https://www.sec.gov/Archives/edgar/data/1757499/0001493152-26-028301-index.html","accession_number":"0001493152-26-028301","cik":"0001757499","ticker":"SHPH","issuer_name":"Shuttle Pharmaceuticals Holdings, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1757499/0001493152-26-028301-index.html","primary_entity_key":"0001757499","primary_entity_name":"Shuttle Pharmaceuticals Holdings, Inc."},"word_count":83,"has_tables":true,"body_markdown":"**Item\n9.01 Financial Statements and Exhibits.**\n\n \n\n*(d)\nExhibits*\n\n \n\n**Exhibit\nNo.**\n \n**Description**\n\n3.1\n \n[Certificate of Amendment of Shuttle Pharmaceuticals Holdings, Inc](ex3-1.htm)\n\n104\n \nCover\nPage Interactive Data File (embedded within the inline XBRL document)\n\n \n\n \n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant\nto the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by\nthe undersigned hereunto duly authorized.\n\n \n\nDated:\nJune\n11, 2026\n \n\n \n \n \n\nSHUTTLE\nPHARMACEUTICALS HOLDINGS, INC.\n \n\n \n \n \n\nBy:\n*/s/\nChristopher Cooper*\n \n\nName:\nChristopher\nCooper\n \n\nTitle:\nInterim\nCo-Chief Executive Officer"}